与卵巢癌转移有关的microRNA研究进展

卵巢癌是女性生殖系统三大恶性肿瘤之一,其致死率居于各类妇科肿瘤之首,是严重影响妇女生命的重要疾患,卵巢癌的转移则是造成病人死亡的重要因素。近年来随着microRNA（又称miRNA或微RNA）作为一种小分子非编码RNA被发现,证实miRNA的作用与各类肿瘤有着重要的联系,这些肿瘤包括乳腺癌、食管癌、胰癌、口腔癌等。近几年的研究表明,miRNA可以影响卵巢癌的发生与发展,并与其转移也存在着紧密的关系。与卵巢癌转移有关的miRNA作用机制的揭示,将会为转移性卵巢癌的诊断及治疗提供新的途径。本综述在通过检索近年来最新文献的基础上,对于卵巢癌的转移机理进行了详尽的分析,并对miRNA在卵巢癌转移中的重要研究予以了详细的阐述。     

与卵巢癌转移有关的microRNA 研究进展

卵巢癌是女性生殖系统三大恶性肿瘤之一,其致死率居于各类妇科肿瘤之首,是严重影响妇女生命的重要疾患,卵巢癌的转移则是造成病人死亡的重要因素.近年来随着microRNA(又称miRNA或微RNA)作为一种小分子非编码RNA被发现,证实miRNA的作用与各类肿瘤有着重要的联系,这些肿瘤包括乳腺癌、食管癌、胰癌、口腔癌等.近几年的研究表明,miRNA可以影响卵巢癌的发生与发展,并与其转移也存在着紧密的关系.与卵巢癌转移有关的miRNA作用机制的揭示,将会为转移性卵巢癌的诊断及治疗提供新的途径.本综述在通过检索近年来最新文献的基础上,对于卵巢癌的转移机理进行了详尽的分析,并对miRNA在卵巢癌转移中的重要研究予以了详细的阐述.     

miRNA表达谱与上皮性卵巢癌

Micro RNA(miRNA)是近年来研究发现的一种高度保守,长度大约19-25个核苷酸的非编码小分子RNA,起着调控基因表达的作用。目前认为miRNA能调控细胞周期、凋亡、分化、发育和新陈代谢等,参与肿瘤的发生与发展,因此异常表达的miRNAs表达谱有可能成为一种全新的肿瘤分子标记物。相关研究表明,miRNA能够以一种被保护的状态存在于血清及血浆中,因此miRNA表达谱的发现具有易检测性、重现性以及非侵袭性。研究显示血清及血浆中miRNA表达谱可作为上皮性卵巢癌生物信号分子,在上皮性卵巢癌早期诊断、预后判断和化疗药物应用等方面具有不可替代的作用。本文将对miRNA表达谱与上皮性卵巢癌的关系进行一个简单总结。     

miRNA的生物形成及调控基因表达机制

微RNA(microRNA,miRNA)通过调节靶基因的表达水平影响细胞分化、增殖、凋亡等特性,在生物的生长发育和疾病发生发展中发挥重要的作用。将miRNA用于基因功能研究,药物靶点验证,基因治疗等领域有非常好的前景。揭示miRNA的生成和加工过程以及miRNA调节靶基因基因表达水平的作用机制对于阐述miRNA在生理病理过程中的作用有重要意义。因此,本文对miRNA的发生,成熟以及作用机制的研究进展作综述。     

动物中microRNA 的保守性和进化历程

microRNA 是一类长度约为22 个核苷酸的内源性非编码单链RNA, 在后生动物中普遍存在, 在转录后过程调控基因表达. miRNA 在个体发育过程中发挥着各种功能, 如发育时序调控和细胞分化、神经发育等. miRNA 在各种后生动物中具有保守性, 而且多个关键类群的出现皆伴随着大量新miRNA 的产生, 这些现象都表明miRNA 与动物的系统发生密切相关. 本文从miRNA 的产生和作用机制、在后生动物中的分布格局及其在个体发育中的调控功能3 个方面论述了miRNA 的保守性, 并结合miRNA 的发生和发展历程, 探讨了miRNA 在动物进化中起到的重要作用.     

中国科学家发现miRNA参与细胞辐射敏感性新机制

<正>中科院近代物理研究所首次发现:microRNA(miRNA)通过靶向调控关键的DNA损伤传感因子ATR增强电离辐射诱导的细胞凋亡及增殖抑制,研究成果在Cell Death&Disease发表。miRNA参与多种生命进程,如细胞生长与分化、凋亡、发育、癌症发生等。现已证实,miRNA在细胞辐射应激响应过程中发挥重要作用,能够参     

MicroRNA及其在昆虫学中的研究进展

MicroRNA(miRNA)是真核生物中对转录后调控起着重要作用的一类非编码单链RNA分子,参与调控胚胎发育、干细胞分化、神经发生及细胞凋亡等几乎所有的生物过程。本文简要总结了miRNA的生物合成、命名、表达及功能等方面的研究进展,同时从昆虫miRNA的鉴定、表达及功能、miRNA的代谢等方面对miRNA在昆虫学研究中的最新进展做了综述。     

microRNA-214在恶性肿瘤中的表达及相关性的研究进展

微小RNA(microRNA,miRNA)是广泛存在于动植物中的一类不编码蛋白质的短小的单链RNA分子,一般由22个核苷酸组成,它们可以特异性地结合mRNA并通过降解或抑制其翻译而在转录后水平调控基因表达。miRNA的表达及功能可影响许多表观遗传学特征,其功能涉及细胞的发生、生长、发育、分化和凋亡过程,在肿瘤的形成和进展过程中扮演重要角色。microRNA-214(miRNA-214,miR-214)参与肝癌、乳腺癌、宫颈癌、卵巢癌、恶性黑色素瘤、胃癌、胶质瘤、儿童骨肉瘤等恶性肿瘤的发生发展,以及与肿瘤细胞的侵袭及转移密切相关。miRNA-214在不同的肿瘤中表达水平并不相同,miRNA-214在不同肿瘤中的差异表达是通过调控某个或者某些癌基因及抑癌基因而实现其参与肿瘤的发生发展、侵袭及转移的作用。因此,本文主要通过阅读大量国内外文献,总结和概括了miRNA-214参与部分恶性肿瘤发生发展的机制。虽然目前对于miRNA的理论研究已经日渐完善和成熟,但是怎样将这些研究结果应用于临床,怎样能够更准确、更便捷的通过对miRNA的检测达到对疾病的诊断、治疗以及预后评估,想必一定会成为将来研究的热点,我们期待一种新型的恶性肿瘤的分子标志物会使越来越多的肿瘤患者获益。     

MicroRNA调控机制及在脂肪形成中的作用

MicroRNA(miRNA)是近几年发现的一类通过转录后调控机制对基因进行调控的非编码的短链RNA,广泛存在于真核生物。miRNAs在个体时序性发育、细胞增殖分化和凋亡、器官发育、脂肪代谢等许多生物发育过程中起着重要作用,并与肿瘤等疾病发生发展密切相关。近年来对miRNA的研究证实,大量miRNA参与脂肪组织发育相关的许多生物学过程调控。主要涉及miRNA的生物合成、调控靶基因转录后表达的机制(如降解mRNA序列、阻断翻译起始、处理小体转位及翻译激活),及其在脂肪形成中的作用,以期为更好地理解miRNA在脂肪形成中的作用,深入研究脂肪形成的分子机制提供参考。     

精神分裂症相关单核苷酸多态性调控microRNA功能研究进展

MicroRNA(miRNAs)是一类长约22nt且对基因表达具有广泛的调控作用的非编码RNA,并在神经元增殖、分化和发育成熟的过程中扮演重要角色。近年来全基因组关联研究(genome-wide association studies, GWAS)发现了众多的精神分裂症相关单核苷酸多态性(single nucleotide polymorphisms, SNPs)位点多位于非编码区,表明miRNA在精神分裂症的发病过程中存在重要作用。本文综述了精神分裂症相关SNP与miRNA可能发生相互作用的4种机制(SNP位于miRNA基因、SNP位于miRNA宿主基因、SNP位于miRNA种子序列和SNP位于miRNA结合位点),为研究miRNA在精神分裂症发生发展中的作用提供参考。     

The role of microRNAs in ovarian cancer initiation and progression

Epithelial ovarian cancer (EOC) has the highest mortality rate of all gynaecological cancers. One of the greatest impediments to improving outcome is an incomplete understanding of the molecular underpinnings of EOC pathogenesis and progression. Recent studies suggest that microRNAs (miRNAs) are involved in ovarian tumorigenesis and cancer development. Several miRNA profiling studies have identified some consensus aberrantly expressed miRNAs in EOC tissues, and these EOC-related miRNAs may play critical roles in the pathogenesis and progression of EOC. Moreover, some of the miRNAs may have diagnostic or prognostic significance. In this review, recent progress to reveal the role of miRNAs in EOC will be addressed, and a model for miRNA functions in ovarian cancer initiation and progression will be proposed.     

Role of microRNAs in ovarian cancer pathogenesis and potential clinical implications

Despite important improvements over the past two decades, the overall cure rate of epithelial ovarian cancer (EOC) remains only ～30%. Although much has been learned about the proteins and pathways involved in early events of malignant transformation and drug resistance, a major challenge still remaining is the identification of markers for early diagnosis and prediction of response to chemotherapy.Recently, it has become clear that alterations in the expression of microRNAs (miRNAs) contribute to the pathogenesis and progression of several human malignancies. In this review we discuss current data concerning the accumulating evidence of the role of miRNAs in EOC pathogenesis and tumor characterization; their dysregulated expression in EOC; and their still undefined role in diagnosis, prognosis and prediction of response to therapy. The most frequently deregulated miRNAs are members of the let-7 and miR-200 families, the latter involved in epithelial-to-mesenchymal transition (EMT). EMT is part of normal ovarian surface epithelium physiology, being the key regulator of the post-ovulatory repair process, and failure to undergo EMT may be one of the events leading to transformation. A general down-modulation of miRNA expression is observed in EOC compared to normal tissue. However, a clear consensus on the miRNA signatures associated with prognosis or prediction of response to therapy has not yet been reached.     

Circulating exosomal miRNAs in cardiovascular disease pathogenesis: New emerging hopes

Cardiovascular diseases (CVDs) are one of the leading causes of morbidity and mortality. Standard therapies have failed to significantly increase patients’ survival. Moreover, the majority of conventional screening procedures are ineffective for the diagnosis of CVDs at early stages. Accumulating evidence suggests that numerous cell types release a class of nano-sized vesicles named exosomes into the extracellular space. Exosomes are widely distributed in various body fluids and contain a number of diverse biomolecules such as proteins, lipids, and both mRNA and noncoding RNAs which reflect host-cell molecular architecture. MicroRNAs (miRNAs), which can be found in exosomes, could be taken up by both neighboring and distal cells. Not only has recent evidence indicated the regulatory role of exosomal miRNAs in the pathogenesis of CVD, but it has also been shown that differential expression of exosomal miRNAs in CVDs has made them promising biomarkers for early detection of CVDs. Owing to these remarkable features, exosomal miRNAs have emerged as hot spots in research. This review summarizes the role of exosomal miRNAs in the pathogenesis of CVDs and discusses their potential application in the clinical setting as both therapeutic and diagnostic tools.     

MicroRNA regulatory networks in the pathogenesis of sarcopenia

Sarcopenia is an age‐related disease characterized by disturbed homeostasis of skeletal muscle, leading to a decline in muscle mass and function. Loss of muscle mass and strength leads to falls and fracture, and is often accompanied by other geriatric diseases, including osteoporosis, frailty and cachexia, resulting in a general decrease in quality of life and an increase in mortality. Although the underlying mechanisms of sarcopenia are still not completely understood, there has been a marked improvement in the understanding of the pathophysiological changes leading to sarcopenia in recent years. The role of microRNAs (miRNAs), especially, has been clearer in skeletal muscle development and homeostasis. miRNAs form part of a gene regulatory network and have numerous activities in many biological processes. Intervention based on miRNAs may develop into an innovative treatment strategy to conquer sarcopenia. This review is divided into three sections: firstly, the latest understanding of the pathogenesis of sarcopenia is summarized; secondly, increasing evidence for the involvement of miRNAs in the regulation of muscle quantity or quality and muscle homeostasis is highlighted; and thirdly, the possibilities and limitations of miRNAs as a treatment for sarcopenia are explored.     

Implications of the noncoding RNAs in rheumatoid arthritis pathogenesis

Epigenetics refers to a set of regulatory mechanisms that affect gene expression, while the original sequence of the DNA remains unchanged. Because the advance of noncoding RNAs (ncRNAs), the role of microRNAs (miRNAs) has been gradually highlighted in the regulation of numerous cellular processes. A bulk of studies has identified that ncRNAs might be divided into several subtypes. On the one hand, investigations have disclosed the role of these molecules in normal physiological conditions of the cells. On the other hand, there is sufficient evidence that ncRNAs participate in the pathogenesis of diseases. Through this review article, we attempted to gain a comprehensive understanding of the role of ncRNAs, long ncRNAs, miRNAs, and other subtypes in pathogenesis, diagnosis, and treatment of rheumatoid arthritis (RA). Research demonstrated aberrant expression of several miRNAs in various cell and tissue types of patients with RA in comparison to the healthy individuals as well as in animal studies. Furthermore, plausible molecular mechanisms of alterations in ncRNAs expression has been discussed in causing the disease state. These alterations seem promising to be used as biomarkers in RA diagnosis. Alternately, they might be targeted by drugs to interrupt inflammation and other disease complications to treat patients with RA.     

MiRNAs and inflammatory bowel disease: An interesting new story

Inflammatory bowel disease (IBD), as a chronic and recurrent inflammatory disorder, is caused by a dysregulated and aberrant immune response to exposed environmental factors in genetically susceptible individuals. Despite huge efforts in determining the molecular pathogenesis of IBD, an increasing worldwide incidence of IBD has been reported. MicroRNAs (miRNAs) are a set of noncoding RNA molecules that are about 22 nucleotides long, and these molecules are involved in the regulation of the gene expression. By clarifying the important role of miRNAs in a number of diseases, their role was also considered in IBD; numerous studies have been performed on this topic. In this review, we attempt to summarize a number of studies and discuss some of the recent developments in the roles of miRNAs in the pathophysiology, diagnosis, and treatment of IBD.     

Circulating Exosomal miR-1290 for Diagnosis of Epithelial Ovarian Cancer

The aim of the study was to develop a new diagnostic biomarker for identifying serum exosomal miRNAs specific to epithelial ovarian cancer (EOC) and to find out target gene of the miRNA for exploring the molecular mechanisms in EOC. A total of 84 cases of ovarian masses and sera were enrolled, comprising EOC (n = 71), benign ovarian neoplasms (n = 13). We detected expression of candidate miRNAs in the serum and tissue of both benign ovarian neoplasm group and EOC group using real-time polymerase chain reaction. Immunohistochemistry were constructed using formalin fixed paraffin embedded (FFPE) tissue to detect expression level of suppressor of cytokine signaling 4 (SOCS4). In the EOC group, miRNA-1290 was significantly overexpressed in serum exosomes and tissues as compared to benign ovarian neoplasm group (fold change ≥ 2, p < 0.05). We observed area under the receiver operating characteristic curve (AUC) for miR-1290, using a cut-off of 0.73, the exosomal miR-1290 from serum had AUC, sensitivity, and specificity values of 0.794, 69.2 and 87.3, respectively. In immunohistochemical study, expression of SOCS4 in EOC was lower than that in benign ovarian neoplasm. Serum exosomal miR-1290 could be considered as a biomarker for differential diagnosis of EOC from benign ovarian neoplasm and SOCS4 might be potential target gene of miR-1290 in EOC.